Antiviral activity and resolution of 2-hydroxymethyl-5-(5-flurocytosin-1-yl)- 1,3-oxathiolane

Details for Australian Patent Application No. 2008201984 (hide)

Owner Emory University

Inventors Schinazi, Raymond F.; Choi, Woo-Baeg; Liotta, Dennis C.

Agent Davies Collison Cave

Pub. Number AU-B-2008201984

Parent 2004200957

Filing date 5 May 2008

Wipo publication date 29 May 2008

Acceptance publication date 27 January 2011

International Classifications

C07D 411/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

22 May 2008 Complete Application Filed

29 May 2008 Application Open to Public Inspection

  Published as AU-B-2008201984

27 January 2011 Application Accepted

  Published as AU-B-2008201984

26 May 2011 Standard Patent Sealed

8 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008201985-Online scheduling system for professionals

2008201983-Method of manufacture of 1,3-oxathiolane nucleosides